2Kim J E. Pharmacokinetic Properties and bioequivalenceof 2 formulations of valsartan 160-mg tablets: a ran- domized, single-dose, 2-period crossover study in health- y korean male volunteers[J]. Clin Ther, 2014,36 (2) : 273-279.
3Chadha R. Valsartan inclusion by methyl-fl-cyclodex- trin thermodynamics, molecular modelling, Tween 80 effect and evaluation[J]. Carbohydr Polym, 2014, 103 (2) : 300-309.
4Vitlyanova K. E{fects of the angiotensin receptor bloc- ker valsartan (valsacor?) on arterial pressure,indices of myocardial diastolic function and global longitudinal strain in patients with uncontrolled arterial hypertension [J]. Vnitr Lek,2013,59(12) :1124-1128.
